Guidance

Breast implants: reporting adverse incidents:

Guidance for manufacturers on reporting adverse incidents involving breast implants under the vigilance system.

From:
Medicines and Healthcare products Regulatory Agency
Published
15 January 2025

Documents

Device-specific vigilance guidance: breast implants

HTML

Details

Guidance for manufacturers on reporting adverse incidents involving breast implants under the vigilance system.

To be read in conjunction with the guidelines on post-market surveillance.

Updates to this page

Published 15 January 2025

Sign up for emails or print this page